Concepedia

Author

Junya Fujimoto

The University of Texas MD Anderson Cancer CenterORCID

Also Known As

Alexander J. Lazar, Cesar Moran, Charles Guo, David Rice, Eiji Tahara, Fujimoto, Junya, Funda Meric-Bernstam, Hidetoshi Tahara, Humam Kadara, J Fujimoto

683

Publications

52K

Citations

83

H-Index

126

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterThe University of Texas Southwestern Medical CenterMemorial Sloan Kettering Cancer CenterNagasaki UniversityBaylor College of Medicine
JF

About

Junya Fujimoto is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and lung cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

30

49

6.8K

2

Engineering

10

11

1.5K

3

Health Sciences

5

5

1.7K

4

Natural Sciences

2

2

94

5

Biostatistics

1

1

17

Junya Fujimoto

×

137

Publications

16.9K

Citations

61

H-Index

YearCitations

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

Jianjun Zhang, Junya Fujimoto, Jianhua Zhang,

Science

2014

975

Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines

Kyle Ellrott, Matthew H. Bailey, Gordon Saksena,

Cell Systems

2018

895

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park,

Cancer Cell

2021

864

Targeting DNA Damage Response Promotes Antitumor Immunity through STING-Mediated T-cell Activation in Small Cell Lung Cancer

Triparna Sen, B. Leticia Rodriguez, Limo Chen,

Cancer Discovery

2019

841

A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

David L. Rimm, Gang Han, Janis M. Taube,

JAMA Oncology

2017

747

Integrative Molecular Characterization of Malignant Pleural Mesothelioma

Julija Hmeljak, Francisco Sánchez-Vega, Katherine A. Hoadley,

Cancer Discovery

2018

585

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Tina Cascone, William N. William, Annikka Weissferdt,

Nature Medicine

2021

582

Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1

Lauren A. Byers, Jing Wang, Monique B. Nilsson,

Cancer Discovery

2012

555

Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas

Franz X. Schaub, Varsha Dhankani, Ashton C. Berger,

Cell Systems

2018

434

Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics

Li Ding, Matthew H. Bailey, Eduard Porta‐Pardo,

Cell

2018

425

Page 1